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Abstract 
Human Immunodeficiency Virus-1 (HIV-1), the causative agent of AIDS, impacts millions of 
people. Entry into target cells is mediated by the HIV-1 envelope (Env) glycoprotein interacting 
with host receptor CD4, which triggers conformational changes allowing binding to a coreceptor 
and subsequent membrane fusion. Small molecule or peptide CD4-mimetic drugs mimic CD4’s 
Phe43 interaction with Env by inserting into the conserved Phe43 pocket on Env subunit gp120. 
Here, we present single-particle cryo-EM structures of CD4-mimetics BNM-III-170 and M48U1 
bound to a BG505 native-like Env trimer plus the CD4-induced antibody 17b at 3.7Å and 3.9Å 
resolution, respectively. CD4-mimetic-bound BG505 exhibits canonical CD4-induced 
conformational changes including trimer opening, formation of the 4-stranded gp120 bridging 
sheet, displacement of the V1V2 loop, and formation of a compact and elongated gp41 HR1C 
helical bundle. We conclude that CD4-induced structural changes on both gp120 and gp41 Env 
subunits are induced by binding to the gp120 Phe43 pocket.  
 
 
Introduction 
Human Immunodeficiency Virus 1 (HIV-1) is the causative agent of Acquired Immunodeficiency 
Syndrome (AIDS) and currently infects over 37.5 million people1. Entry of HIV-1 into host target 
cells is initiated by binding of the host receptor CD4 to the only viral protein on the surface of 
HIV-1, the envelope (Env) glycoprotein, a trimer of gp120-gp41 heterodimers2. Env binding to 
CD4 induces a well-characterized set of conformational changes3-6 that expose an occluded 
binding site in the gp120 V3 region for a co-receptor, either CCR5 or CXCR47. Upon co-receptor 
binding, Env undergoes further conformational changes resulting in insertion of the gp41 fusion 
peptide into the target cell membrane, allowing fusion of the viral and host membranes and 
entry of the HIV-1 genetic material into the target cell2. 
 
X-ray and cryo-EM structures of native-like soluble HIV-1 Env trimers (SOSIPs8) have defined a 
closed, prefusion state in which the V1V2 loops at the trimer apex shield the co-receptor binding 
site on the V3 region9, and a CD4-bound open state in which the gp120 subunits rotate 
outwards from the trimer axis, the V1V2 loops are displaced to the sides of the trimer, and the 
V3 loops are exposed3-6. A key interaction for exposure of the co-receptor binding site upon 
CD4 binding is the insertion of CD4 residue Phe43CD4 into a conserved, 150Å
2 hydrophobic 
cavity at the junction between the gp120 inner domain, outer domain, and bridging sheet10. This 
interaction was first observed in crystal structures of monomeric gp120 cores complexed with 
CD410, which adopt a hallmark feature of CD4-bound Env trimers in the presence or absence of 
CD4: a 4-stranded anti-parallel β-sheet comprising β-strands β20, β21, β2, and β3.11. By 
contrast, SOSIP Env trimers in the closed, prefusion state contain a mixed parallel/anti-parallel 
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3-stranded β-sheet comprising strands β20, β21, and β312. Upon CD4 binding to an Env trimer, 
the loop between strands β20 and β21 is displaced, triggering changes that are propagated 
through the inner domain of gp120 and resulting in trimer opening, V1V2 displacement, and 4-
stranded bridging sheet formation3-6. Identification of the importance of the gp120 Phe43 cavity 
for CD4 binding led to development of cavity-interacting small molecule and peptide compounds 
called CD4 mimetic (CD4m) inhibitors13-20. 
 
Small molecule HIV-1 entry inhibitors that prevent HIV-1 trimer opening include BMS-378806 
and a related family of compounds including BMS-626529, which bind orthogonally to the 
Phe43 opening beneath the Env β20-21 loop and extend into the base of the Phe43 cavity. 
Upon inhibitor binding, the Env trimer is kept closed by allosterically preventing CD4 binding by 
separating the bridging sheet and the inner domain of gp12020,21.  
 
CD4m compounds that open trimers by binding directly into the Phe43 pocket were initially 
identified with the discovery of NBD-556 and NBD-557, two small molecules that inhibit HIV-1 
entry into cells expressing CD4 and a co-receptor, but enhance entry into cells that express a 
co-receptor in the absence of CD413. Subsequent studies showed that premature allosteric 
activation of trimer opening by these small molecules could inhibit viral entry after an initial 
period of increased activation22, leading to modification of these compounds and the 
development of CD4m small molecule inhibitors such as BNM-III-170 that bind to the Phe43 
pocket but prevent infection of cells lacking CD413,14. Members of this class were also shown to 
induce an intermediate Env conformation that can be stabilized by gp120 inner-domain-
targeting Abs, permitting Antibody-Dependent Cellular Cytotoxicity23. 
 
Concurrent with the development of small molecule CD4m inhibitors, peptide CD4m inhibitors 
were developed using scorpion toxin scyllatoxin scaffolds in which the CDR2-like loop of CD4 
containing Phe43 had been grafted24-26. Unlike small molecule CD4m compounds, which 
primarily insert directly into the Phe43 cavity with few external interactions, CD4m peptides 
contain a more extensive gp120 binding interface involving not only a synthetic Phe43-
equivalent residue, but also an equivalent to Arg59CD4, which forms a salt bridge with the highly-
conserved Asp368gp120
10 and an exposed C-terminal β-strand that forms hydrogen bonds with 
the β15 strand of gp120 immediately adjacent to the Phe43 cavity opening15. These peptides 
directly compete with CD4 binding and inhibit HIV-1 infection of cells24,25. 
 
Recent reports of structures of CD4-bound partially-open5 and fully-open but asymmetric Env 
trimers6 demonstrated that there are different conformations of open HIV-1 Env trimers. In 
addition, the structure of an Env trimer bound to the CD4-binding site antibody b12 exhibited yet 
another open Env conformation4. Here we investigated the open conformation(s) of HIV-1 Env 
induced by two CD4m compounds: BNM-III-170, a small molecule, and M48U1, a peptide, both 
of which have been structurally characterized when bound to gp120 monomeric cores14,15.We 
report single-particle cryo-EM structures of complexes of these trimer-opening CD4m 
compounds with the BG505 SOSIP.664 trimer8 (hereafter BG505), which provide information 
about potential V1V2 displacement, V3 rearrangement, and gp41 changes that cannot be 
assessed in structures involving gp120 monomeric cores. These structures revealed 
interactions of CD4m compounds with the Phe43 cavity in complexes with three CD4m and 
three 17b Fabs per BG505 trimer. Inter-protomer dimensions of M48U1 and BNM-III-170-bound 
Env closely matched those of an open, sCD4-bound Env. In addition, the CD4m-Env structures 
exhibited canonical features of CD4-bound open trimer for all three protomers, including a 4-
stranded bridging sheet, a displaced V1V2 loop, an exposed and displaced V3 loop, and a 
compact arrangement of extended gp41 HR1C helices. We conclude that BNM-III-170 and 
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M48U1 induce Env trimers to open in a similar manner as the native CD4 ligand despite fewer 
contacts with gp120. 
  
Results 
 
M48U1-BG505 and BNM-III-170-BG505 complexes bind 17b IgG 
17b, a CD4-induced (CD4i) antibody that binds Env only when the gp120 V3 loop is exposed 
after V1V2 loop displacement characteristic of CD4-induced Env opening, has been used as a 
measure of trimer opening3-6,27,28. We first recapitulated and extended studies showing that 
binding of BNM-III-170 and M48U1 CD4m compounds open Env trimers29,30 as assessed by a 
17b binding assay31. D7324-tagged BG505 trimers8 were immobilized on ELISA plates by 
binding to the JR-52 antibody as described8 and then incubated with either buffer, BNM-III-170, 
M48U1, BMS-626529, or soluble CD4 (sCD4), and the binding of CD4-induced antibodies 17b 
and 21c, V1V2 bNAbs BG1 and PG16, and V3 bNAb 10-1074 was measured.  
 
BG1, PG16, and 10-1074 IgGs bound to BG505 under both closed and open conditions 
(Supplementary Fig. 1a). As expected, BG505 did not bind17b or 21c IgGs in the absence of 
sCD4 or BNM-III-170 and M48U1 inhibitors, indicating the Env trimers were well-folded. When 
incubated with BNM-III-170, M38U1, or sCD4, BG505 bound to 17b IgG, confirming previous 
results29,30 and demonstrating accessibility of the V3 loop in an open state (Supplementary Fig. 
1b-d). Of note, binding of 17b was lower for BG505 incubated with BNM-III-170 (Supplementary 
Fig. 1c), suggesting that some of the BG505 Envs were in a conformation not accessible for 
binding to 17b. 21c IgG bound to BG505 plus sCD4, but did not bind to BG505 incubated with 
BNM-III-170 or M48U1 (Supplementary Fig. 1b-d), consistent with the requirement of the 
epitope of this antibody spanning CD4 and gp12032. BG505 incubated with BMS-626529 
showed little or no binding to 17b IgG, consistent with a BG505–BMS-626529 crystal structure 
in the closed, prefusion state20 (Supplementary Fig. 1a).  
 
These results demonstrated that binding of M48U1 and BNM-III-170 caused BG505 Env trimer 
to adopt a conformation in which the 17b binding site on V3 was exposed. 
 
Cryo-EM structures of BNM-III-170-BG505-17b and BG505-M48U1-17b complexes show 
densities for CD4m compounds 
Although the BNM-III-170 and M48U1 CD4m compounds demonstrated 17b binding consistent 
with trimer opening, it was not known if other CD4-induced conformational changes in Env took 
place since the CD4 binding site on gp120 encompasses more than the CD4 Phe43 sidechain 
interacting with the gp120 Phe43 pocket. For example, other conserved interactions with gp120 
include CD4 residues 29, 33, 34, 44, and 5910.  
 
We used single-particle cryo-EM to determine the structural effects of binding BNM-III-170 and 
M48U1 to an HIV-1 Env trimer. For structure determinations, BG505 was incubated with a 
CD4m and 17b Fab and then purified by size exclusion chromatography (SEC) to obtain CD4m-
BG505-17b complexes. Samples were frozen on grids in vitrified ice and micrographs were 
collected on a Titan Krios microscope. 3D reconstructions were produced by iterative 2D 
classification and 3D refinement without 3D classification followed by polishing33,34. Final 
reconstructions were produced for each complex at 3.7Å for BNM-III-170-BG505-17b and 3.9Å 
for M48U1-BG505-17b, as determined by the gold-standard FSC35 (Fig. 1a,b; Supplementary 
Fig. 2,3). Both structures were solved by fitting three copies of the gp120 and gp41 coordinates 
for open conformation A from a single-particle cryo-EM structure of sCD4-E51-BG5056 and 
three copies of 17b Fab variable domain coordinates36. Initial models were refined without 
placement of CD4m compounds. Following refinement, density that could not be accounted for 
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by Env or 17b Fab was present within the Phe43 pockets in all gp120 protomers of both maps. 
Overlaying of the BNM-III-170-gp120 and M48U1-gp120 crystal structures14,15 allowed 
placement of the CD4m compounds into these densities within the Phe43 pocket.  
 
CD4m-bound BG505 trimers displayed conformational heterogeneity 
During processing of both CD4m-BG505 data sets, it became clear that one protomer in each 
structure had consistently worse density for the gp120 and 17b regions (Supplementary Fig. 
4a). To determine if the lower resolution of this region in the BNM-III-170-BG505-17b complex 
resulted from sub-stoichiometric binding of 17b Fab, we performed iterative rounds of 3D 
classification (Supplementary Fig. 4b). Rather than yielding classes with different 17b binding 
stoichiometries, the analysis produced nearly identical classes with 17b Fab densities for all 
protomers and similar numbers of particles in each class regardless of the number of 
subclasses (k= 2, 4, or 8) defined. Overlaying and alignment of the reconstructions showed that 
the 17b Fab with the weakest density was rotated at varying degrees away from the central axis 
of the Env in each subclass, but the resulting 3D classes were of poorer resolution (6-8Å) and 
precluded detailed analysis to identify differences in conformation of the trimers in each 
subclass. To improve the resolutions of the subclasses, we collected a second data set for the 
BNM-III-170-BG505-17b complex and repeated the analysis with more particles. Classification 
and analysis of the merged data produced similar 3D classes as in the first data set, but at a 
higher resolution (~6Å) with close overlays of two protomers (defined as protomers 1 and 2) and 
different positions for protomer 3 (Supplementary Fig. 4c). Re-fitting gp120 and gp41 
coordinates into the gp120 densities revealed that the position of the gp120 core changed 
between classes and hinged as a rigid body about the gp120 β4 and β26 strands. Since 
protomers in all 3D classes showed similar conformations and the overall resolution was better 
for the combined reconstruction, we performed analyses on the models built and refined into the 
maps containing all particles without 3D classification (Fig. 1). This resulted in a 3.7Å map of the 
BNM-III-170-BG505-17b complex with two well-defined gp120-gp41-17b protomers and one 
protomer with weaker density for 17b and gp120. As classification results for M48U1-BG505-
17b were similar (Supplementary Fig. 5), we also retained all particles without 3D classification 
for the final reconstruction at 3.9Å resolution. 
 
BNM-III-170 and M48U1 bind in Phe43 pockets of BG505 Env trimer  
While the overall resolution of the BNM-III-170-BG505-17b complex was 3.7Å, the local 
resolution for the gp120 Phe43 pocket was ~3.5Å (Supplementary Fig. 4a), and with the 
exception of Glu478gp120, there was density for sidechains of gp120 residues lining the Phe43 
pocket in protomers 1 and 2 (Supplementary Fig. 6a). Alignment of the gp120s from the BNM-
III-170-BG505-17b complex with the monomeric core gp120 from the BNM-III-170-gp120 crystal 
structure14 demonstrated structural similarity (root mean square deviation, RMSD, = 1.2-1.3 Å 
for 320 Cα atoms), and the BNM-III-170 from the gp120 core complex structure14 aligned with 
the unaccounted density in the cryo-EM reconstruction (Supplementary Fig. 7a). In this position, 
BNM-III-170 fit into the gp120 Phe43 pocket beside the gp120 β20-β21 loop. In sCD4-bound 
gp120 structures, there is an 8Å gap between the tip of the phenyl ring of the Phe43CD4 residue 
and the base of the Phe43 hydrophobic cavity in gp120, leading to the development of CD4m 
such as BNM-III-170 that reach further into the pocket13. As also found in the BNM-III-170-
gp120 core structure14, the BNM-III-170 molecules extended to the base of each Phe43 cavity 
of each protomer in the BNM-III-170-BG505-17b structure (Fig. 2a). 
 
Interactions between BNM-III-170 and gp120 in the gp120 core structure14 occur near the 
entrance of the Phe43 cavity and involve H-bonds between the guanidinium of BNM-III-170 and 
backbone carbonyls of Arg429gp120 and Met426gp120 and the methyl amine of BNM-III-170 with 
the carbonyl of Gly473gp120.  In addition, a fourth hydrogen bond is formed halfway into the 
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Phe43 cavity between the backbone carbonyl of Asn425gp120 and a hydrogen on the more buried 
nitrogen of the oxalamide linker of BNM-III-17014. Positioning of BNM-III-170 in the highest 
resolution protomer (protomer 1) of the BNM-III-170-BG505-17b structure placed its oxalamide 
linker within hydrogen bonding distance of Asn425gp120 and Gly473gp120 (Fig. 2b), consistent with 
previously-reported interactions14. Poor density for the guanidinium of BNM-III-170 made 
modeling of its orientation with respect to the β-turn of the gp120 the β20-β21 hairpin loop. 
However, the density supported its placement in close proximity to backbone carbonyls of both 
Met426gp120 and Asn429gp120 (Fig. 2b), suggesting that these interactions also occur in the BNM-
III-170-BG505-17b complex.  
 
The density for M48U1 in the M48U1-BG505-17b complex was well ordered, allowing 
placement of its α-helix and two-stranded β-sheet into density along with the coordinates for 
gp120, gp41, and 17b (Fig. 1b, c). As also found for the BNM-III-170-BG505-17b complex, one 
protomer of the BG505 trimer showed weaker density for 17b, gp120, and M48U1 
(Supplementary Fig. 6b). 
 
The cyclohexylmethoxy phenylalanine side chain at M48U1 position 23 occupies a structurally-
equivalent position with respect to Phe43CD4. Whereas Phe43CD4 inserts only 8Å into the gp120 
cavity, the hydrophobic cyclohexylmethoxy phenylalanine inserts and extends ~11.5Å from its 
Cα, reaching to the base of the gp120 Phe43 cavity (Fig. 2b). Unlike BNM-III-170, all polar 
contacts between M48U1 and gp120 occur outside of the Phe43 cavity. The β−strand spanning 
residues Cys24M48U1 to Cys26M48U1 (equivalent to Leu44CD4 to Lys46CD4) forms hydrogen bonds 
with backbone atoms of residues Asp368gp120, Gly367gp120, and Gly366gp120. In previous crystal 
structures, Asp368gp120 was identified as an important binding residue both for Arg59CD4 and for 
the M48U1-equivalent residue Arg9M48U1
10,15. However, reduced sidechain density for the 
M48U1 helix in the M48U1-BG505 structure limited accurate placement of sidechains. 
 
BNM-III-170 and M48U1 open BG505 trimer to a similar degree as CD4 
To evaluate conformations of HIV-1 Env, we previously used distance measurements between 
equivalent residues within gp120 subunits of an Env trimer, from which we could compare the 
degree of gp120 opening between trimers in closed, b12-bound, and sCD4-bound states5,6,37. 
Here we used this method to assess the effects of BNM-III-170 and M48U1 binding on the 
BG505 conformation (Fig. 3). Measurements for the CD4m-BG505 complexes were 
complicated by the lack of three-fold Env trimer symmetry due to the heterogeneity of one of the 
protomers (designated as protomer 3 in each complex) (Supplementary Fig. 4-5). Thus the 
measurements between equivalent residues in protomers 1 and 2 are more accurate than 
measurements between protomers 2 and 3 and between protomers 1 and 3. For distance 
measurement comparisons with sCD4-bound Env trimers, we averaged distances from 
conformations A and B of an asymmetric sCD4-BG505-E51 Fab complex6 and a symmetric 
sCD4-B41-17b complex4. We also averaged measured distances between protomers for each 
CD4m-BG505 complex. We report a single distance for three-fold symmetric Env structures and 
an average distance with a standard deviation for asymmetric structures. 
 
As previously described, the V3 regions of closed Env and b12-bound open Env are occluded 
by the V1V2 loop5 (Fig. 4a,b). Opening of b12- or sCD4-bound Env involves rotation of the 
gp120 as a rigid body away from the central gp41 helices, hinging on the loops connecting the 
β26 and β4 strands to the gp120 core.5,38 A hallmark of sCD4, but not b12, binding to Env 
trimers is displacement of V1V2 to expose the coreceptor binding site on V33,5,6. These 
conformational changes have corresponding changes in positioning of residues in the V1V2 
loop, the V3 loop, and the CD4 binding site (CD4bs) that can be evaluated by measuring 
.CC-BY-NC-ND 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted August 22, 2020. . https://doi.org/10.1101/2020.08.21.261974doi: bioRxiv preprint 
 
 6
between the three copies of Pro124gp120 at the V1V2 base, the three copies of His330gp120 at the 
V3 base, and the three copies of Asp368gp120 at the CD4bs. A typical closed Env structure
39 
displayed V1V2 distances of 14Å and V3 distances of 69Å (Fig. 3b). Similarly, an Env trimer that 
was kept in a closed conformation by the Phe43 cavity-binding small molecule BMS-62652920 
showed V1V2 and V3 inter-protomer distances of 14Å and 55Å, respectively. In sCD4-liganded 
open Env, the displacement of V1V2 from the trimer apex to the sides of Env trimer resulted in 
inter-protomer V1V2 distances of 77 ± 5.9Å and V3 distances of 74Å ± 4Å.  
 
The BNM-III-170-BG505-17b and M48U1-BG505-17b structures both showed similar inter-
protomer measurements as sCD4-bound Envs for V1V2 displacement (74Å ± 3.7Å and 75Å ± 
2.8Å, for the BNM-III-170 and M48U1 complexes, respectively) and V3 positioning (76Å ± 4.6Å 
and 77Å ± 5.9Å, respectively).  
 
Opening of both b12- and CD4-bound trimers leads to hinging about the loops connecting the 
β26 and β4 strands to the main portion of the gp120 subunit and rotation of the gp120 as a rigid 
body away from the central gp41 helices5,38. This is reflected in changes of the average inter-
protomer distances between Asp368gp120 residues in the CD4 binding site: from 54Å and 55Å in 
closed Env structures to 80Å ± 5.0Å in CD4-bound open Env and 85Å ± 0Å for b12-bound open 
Env. The analogous measurements for the CD4m-BG505 complexes (84Å ± 3.4Å and 86Å ± 
4.2Å) suggested that CD4m binding induced equivalent gp120 rotation and displacement 
indicative of trimer opening.  
 
Taken together, the inter-protomer distances for V1V2, V3, and the CD4 binding site provide 
quantitative verification that BNM-III-170 and M48U1 induce an open BG505 structure similar to 
the sCD4-bound open conformation.  
 
BNM-III-170 and M48U1 induce additional structural changes similar to those induced by 
sCD4 binding 
In addition to gp120 rotation and displacement to create an open Env trimer, sCD4-bound Env 
structures exhibit structural changes within the gp120 and gp41 subunits compared with closed 
Env structures. In order to determine if the CD4m-bound Env structures demonstrated similar 
conformational changes as sCD4-bound open Envs, we compared specific regions of closed 
and open Env structures. For comparisons with sCD4-bound Env trimer, we choose 
conformation A from a structure of sCD4-BG505-E51 Fab6 that differs from a slightly different 
conformation (conformation B) also observed for the asymmetric sCD4-BG505-E51 complex6 
and for a symmetric sCD4-B41-17b complex4. 
 
A large conformational change that occurs upon sCD4 binding to Env trimer is displacement of 
V1V2 to expose the coreceptor binding site on V33,5,6. As previously described, the V3 regions 
of closed Env and b12-bound open Env are occluded by the V1V2 loop5 (Fig. 4a-c). The CD4m-
bound open Env complexes showed displacement of the V1V2 loop and exposure of the V3 
loop in a similar manner as in sCD4-bound open Env (Fig. 4b-c). 
 
Accompanying the opening of the V1V2 loop, the 3-stranded β-sheet formed by the β20, β21, 
and β3 strands in closed Env structures12 undergoes a rearrangement upon binding of CD4 in 
which β2 becomes an ordered β-strand and swaps positions with the β3 strand, forming a 4-
stranded β-sheet5,6,38 called the bridging sheet10 (Fig. 4d). Although the b12-bound Env structure 
can be classified as open with respect to its gp120 positions38, it retains the 3-stranded β-sheet 
found in closed Env structures  (Fig. 4d), likely because the V1V2 and V3 regions move as a 
rigid body with gp120 rather than V1V2 being displaced to the sides of Env5. In common with 
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sCD4-bound open Env structures, CD4m-bound Envs included 4-stranded bridging sheets (Fig. 
4d).  
 
The fusion peptide also exists in several conformations: an unstructured loop in closed and b12-
bound open structures versus a helical conformation in sCD4-bound and CD4m-bound open 
conformations (Fig. 4e). In addition, the rotation and repositioning of the gp120 subunits upon 
trimer opening permits the rearrangement of the gp41 helices to form a compact HR1C helical 
bundle, as also found in b12-bound and sCD4-bound open Env trimers (Fig. 4f). The CD4m-
BG505 complexes adopted the same gp120 positioning and gp41 rearrangements as found in 
sCD4- and b12-bound Envs (Fig. 4f). While the HR1C helix became more compact upon 
rearrangement in the CD4m-bound structures, it also extended and formed several additional 
ordered helical turns at the tip of the gp41 bundle that make up part of HR1N (Fig. 4f), as also 
found in the b12- and sCD4-bound open structures, therefore its occurrence in CD4m-bound 
open Env structures suggests this is a conformational change that typically occurs upon trimer 
opening. 
 
In closed or b12-bound Envs, the gp120 α0 region nestled against the top of the gp41 helices is 
in an unstructured loop (Fig. 4g). When sCD4 is bound, the α0 adopts a helical structure and is 
located at the top of the HR1 helix of the adjacent protomer (Fig. 4g). Likewise, the CD4m-
BG505 open structures showed analogous placement and helical α0 conformations to the 
sCD4-bound structure for the three protomers in each Env trimer (Fig. 4g). 
 
We conclude that the CD4m-bound Envs exhibit structural changes within the gp120 and gp41 
subunits characteristic of sCD4-bound open Env structures. 
 
Discussion 
 
Viral fusion protein flexibility is required for their functions in fusing the viral and host cell 
membranes2. Indeed, HIV-1 Env trimers exhibit different degrees of opening in response to 
external signals9. Here, we investigated how the activating CD4m molecules BNM-III-170 and 
M48U1 alter the confirmation of Env trimers. Since the CD4m-gp120 interface is smaller than 
the sCD4-gp120 interface, it was possible that, rather than adopting a fully open conformation 
normally induced by host receptor binding, activating CD4m molecules could induce a partially-
open conformation (e.g., similar to sCD4 plus 8ANC195-bound Env trimers5) or an open 
conformation without V1V2 displacement as in the b12-bound Env trimer4. Alternatively, since 
CD4m molecules have little to no bulk that could interact outside the gp120 Phe43 pocket, they 
could also allow the trimer to adopt a previously-unseen open conformation due to limiting steric 
clashes that would occur in the presence of bound CD4.  
 
Using single-particle cryo-EM, we found that two CD4m compounds, BNM-III-170 and M48U1, 
bound to the native-like BG505 Env trimer resulted in open trimer structures similar to sCD4-
bound structures, both in terms of inter-subunit gp120 rotation and displacement and in terms of 
intra-subunit conformational changes. These results demonstrate that interactions of small 
molecule compounds at the gp120 Phe43 pocket are sufficient to cause Env trimer opening and 
structural rearrangements similar to those induced by the CD4 host receptor. These results can 
be used to inform design of CD4m compounds as possible therapeutics. 
 
 
Methods 
  
Protein Expression and Purification 
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A construct encoding the BG505 SOSIP.664 native-like envelope gp140 trimer including 
stabilizing mutations (A501Cgp120, T605Cgp120, I559Pgp41), an introduced glycosylation site 
(T332Ngp120), an improved furin protease cleavage site (REKR to RRRRRR), and truncation 
after residue 664 in gp418 was subcloned into the pTT5 expression vector (National Research 
Council of Canada) and transiently expressed in HEK293F cells. BG505 trimer was purified 
from supernatant by 2G12 Fab immunoaffinity chromatography followed by SEC using a 
Superdex 200 Increase 10/300 GL column (GE Life Sciences) running in TBS (20mM Tris pH 8, 
150mM NaCl) plus 0.02% NaN3 as described
37. BG505 trimer that was C-terminally tagged with 
the D7324 sequence31 was prepared in the same way. For some experiments, BG505 
SOSIP.664 was expressed and purified from supernatants of a stable CHO cell line (kind gift of 
John Moore, Weill Cornell Medical College) as described40. 
 
Expression plasmids encoding JR-52 IgG were the kind gift of James Robinson (Tulane 
University) and John Moore (Weill Cornell Medical College). Expression plasmids encoding the 
heavy and light chains of 17b, BG1, 21c, PG16, 10-1074, JR-52 IgGs were transiently co-
transfected into Expi293F cells (Gibco) using Expofectamine (Invitrogen). IgGs were purified 
from supernatants by protein A chromatography (GE Life Sciences) followed by SEC using a 
Superdex 200 Increase 10/300 GL column (GE Life Sciences). IgGs were stored in TBS. 6x-His 
tagged version of 17b Fab and sCD4 (domains 1 and 2 of CD4; amino acids 1-186) were 
expressed as described5.   
 
CD4 mimetic compounds 
The (+)(R,R)BNM-III-170 small molecule (referred to as BNM-III-170 throughout the manuscript) 
was synthesized as described14,41 and stored at -20oC in DMSO until use. Lyophilized M48U1 
peptide (sequence reported in ref.15) was purchased from Presto Pepscan Inc. (Lelystad, The 
Netherlands) and resuspended in DMSO before use.  
 
ELISA 
96-well plates (Corning, #9018) were coated with JR-52 IgG at 5µg/mL in 0.1M NaHCO3 pH 8.6 
at 4oC overnight. sCD4-BG505, BNM-III-170-BG505, M48U1-BG505, and BMS-626529 
complexes were prepared by incubating CD4m with D7324-tagged BG505 trimer31 at a 15:1 
small molecule to trimer ratio or a 6:1 sCD4 to trimer overnight at room temperature in TBS. 
Plates were blocked on the following day for 1hr with TBS-TMS (20mM Tris pH 8, 150mM NaCl, 
0.05% Tween 20, 1% non-fat dry milk, 1% goat serum (Gibco 16210-072)). Complexes diluted 
to a final concentration of 10µg/mL in TBS-TMS were incubated on coated plates for 1 hour at 
room temperature and three 10-minute washes were performed using TBS-T (20mM Tris pH 8, 
150mM NaCl, 0.05% Tween 20). IgG versions of 17b, 21c, BG1, PG16, and 10-1074 were 
diluted from 20µg/µL to 1ng/µL in 2-fold increments. Plates with trimer complexes were 
incubated with IgGs for 2 hours at room temperature, followed by 3 washes of TBS-T, and then 
incubation for 30 mins at room temperature with anti-human IgG HRP at 1:4000 (Southern 
Biotech #2040-05). 5 washes of TBST were done followed by development using 1-Step Ultra 
TMB-ELISA Substrate Solution (ThermoFisher Scientific, 43028) and quenching with 1N HCl. 
Quantification of results was performed using a plate reader detecting absorbance at 450nm. All 
samples were evaluated in duplicate. After averaging duplicates, data were graphed as the 
mean ± the standard deviation and figures were made using Graphpad Prism v8.  
 
Cryo-EM Sample Preparation 
BNM-III-170-BG505-17b and M48U1-BG505-17b complexes were assembled by incubating 
CD4m compounds BNM-III-170 or M48U1 with BG505 overnight at room temperature at a molar 
ratio of 10:1 (CD4m:trimer). 17b Fab was added the next day at a 9:1 ratio (Fab:trimer) and 
incubated at room temperature for 2-4 hours. Complexes were purified by SEC on a Superdex 
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200 Increase GL 50/150 or a Superdex 200 Increase 10/300 GL column (GE Healthcare) and 
fractions containing CD4m-BG505-17b complexes were concentrated to 1.4-1.5mg/mL. Cryo-
EM grids were frozen using a Mark IV Vitrobot (ThermoFisher) at 22oC and 100% humidity. 
3.1µL of sample was applied to Quantifoil R2/2 300 mesh grids, blotted for 3 or 3.5 seconds, 
and plunge frozen into liquid ethane. Grids were then transferred to grid boxes in liquid nitrogen 
and stored until data collection. 
 
Cryo-EM Data Collection and Processing 
Cryopreserved grids were loaded into a Titan Krios electron microscope (ThermoFisher) 
equipped with a GIF Quantum energy filter (slit width 20eV) operating at 300kV and a nominal 
80,000 magnification. Images were recorded using a K2 Summit direct electron detector (Gatan) 
in counting mode with a pixel size of 1.104Å/pixel and defocus range of 1-3.5µm. Images were 
exposed for a total dose of 40 or 60e-/pixel fractionated into 40 subframes. Micrographs were 
manually curated after motion correction with MotionCor242 and the contrast transfer function 
was fit with Gctf v. 1.0643 to remove cracked or icy micrographs. Initial particles from 100 
randomly selected micrographs were picked using the RELION autopicker33,34, and reference-
free two-dimensional (2D) classes were generated in RELION. Particles from good initial 
classes were used to generate Ab initio models in CryoSPARC44. RELION autopicker was then 
used to pick particles from all micrographs and subjected to 2D reference-free classification in 
RELION. Good 2D classes were selected and subjected to two rounds of 2D classification. 3D 
classification was performed on 2D averages using RELION33,34. The 3D classes were used for 
analysis; however, no 3D classes were discarded before proceeding to 3D refinement and 
polishing. 3D reconstructions were produced in RELION 3D auto-refine using ab initio models 
as starting models33,34. CTF correction and polishing were performed in RELION, and final maps 
were generated after a final round of 3D auto-refining.  
  
Model building 
Coordinates of gp120 (PDB 6U0L, Conformation B), gp41 (PDB 6U0L, Conformation B), and 
17b Fab VH-VL domains (PDB 2NXY) were fitted into map density using UCSF Chimera
45. 
Coordinates were initially refined using phenix.real_space_refine46 from Phenix package ver. 
1.17.147 and manually refined using Coot48. Initial refinement rounds were performed without 
placing CD4m compounds. Placement of BNM-III-170 or M48U1 was done in Chimera by 
overlaying the refined gp120 portions of our cryo-EM structures with corresponding X-ray crystal 
structures of M48U1-gp120 (PDB: 5JZZ) or BNM-III-170-gp120 (PDB: 5F4P), which placed 
CD4m compounds into unambiguous, unaccounted-for density within the Phe43 pocket region 
of gp120. CD4m were then rigid body fit in Chimera to better fit density. Further rounds of 
manual and automated refinement of models containing CD4m were performed. As resolution 
was not sufficient to determine conformations of M48U1 BNM-III-170 in the third protomer, the 
conformations from the crystal structures were modeled into the density using rigid body fitting 
and were not further refined. In addition, we trimmed side chains to Cβ of M48U1-BG505-17b 
protomer 3 gp120,17b VH-VL and M48U1 (except for the cyclohexylmethoxy phenylalanine at 
position 23) due to poor resolution. 
 
Structural analysis 
Structure figures were made using UCSF Chimera45 or PyMol49. Unless otherwise noted, figures 
showing a single gp120-gp41 protomer were made using one of the two protomers (protomers 1 
and 2) in each complex showing the best density.  Potential hydrogen bonds were assigned as 
interactions that were <4.0Å and with A-D-H angle >90˚. Potential van der Waals interactions 
between atoms were assigned as interactions that were <4.0Å. Due to low resolution, hydrogen-
bond and van der Waals interaction assignments should be considered tentative. Inter-protomer 
Cα distances were measured between Cα atoms using the Measurement Wizard tool in PyMOL 
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version 2.3.2. Pairwise Cα alignments between CD4-bound gp120-core structures and CD4m-
bound Env gp120 core structures in Supplementary Fig. 7 were done using the alignment 
function PyMOL v2.3.2 without excluding outliers. Atoms belonging to regions that were not 
present in both gp120 and gp120 core structures were excluded. 
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Figure 1: Cryo-EM structures of BNM-III-170-BG505-17b and M48U1-BG505-17b. a, Top-
down view of density maps for BNM-III-170-BG505-17b and M48U1-BG505-17b complexes. b, 
Side view of density maps for BNM-III-170-BG505-17b and M48U1-BG505-17b complexes. 
Boxed region indicates binding site for one CD4m molecule on each structure. c, Close-up 
views of densities in CD4m binding sites. Densities shown at 7σ. 
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Figure 2: BNM-III-170 and M48U1 binding to the gp120 Phe43 pocket. Atom colors: carbon 
= magenta (BNM-III-170), red (M48U1), or orange (gp120), nitrogen = blue, oxygen = red, sulfur 
= yellow, chlorine = green; fluorine = cyan. a, Cut-away side view of gp120 showing BNM-III-170 
or M48U1 inserting into Phe43 pocket cavity of gp120 (black/grey). b, Left: Stick model of BNM-
III-170 within gp120 Phe43 pocket. Potential interactions between BNM-III-170 and backbone 
atoms of gp120 residues indicated by an arrow pointing to colored atoms of gp120 residues 
(sidechains omitted for clarity). Right: Stick and cartoon model of M48U1 within gp120 Phe43 
pocket.  
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Figure 3: BNM-III-170- and M48U1-bound Env inter-protomer dimensions match those of 
open CD4-bound Env. a, Top-down view of surface and cartoon rendering of BNM-III-170-
bound and M48U1-bound Env trimer structures showing inter-protomer distance measurements 
between reference residues for the base of the V3 loop (His330gp120, blue), the base of the 
V1/V2 loop (Pro124gp120, green), and the CD4 binding site (CD4bs, Asp368gp120, yellow). 17b 
Fabs have been removed for clarity. b, Table of inter-protomer distances for the indicated 
structures.  Distances for three-fold symmetric structures are listed without a standard deviation. 
Distances for sCD4-bound open Env structures were derived from two asymmetric structures of 
sCD4-BG505-E51 (PDBs 6U0L and 6U0N) and one structure of a more symmetric sCD4-B41-
17b (PDB 5VN3). 
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Figure 4: Conformational features of gp120 and gp41 in structures of closed and open 
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Envs. Cartoon and schematic models showing features of the HIV-1 Env trimers in the closed 
conformation (PDB 5T3Z), b12-bound open conformation (PDB 5VN8), sCD4-bound open 
conformation (PDB 6U0L, Conformation A), the BNM-III-170-bound open conformation, and the 
M48U1-bound open conformation. a, Cartoon depiction of BG505 Env with regions of interest 
colored. b, Schematic of gp120 angle with relation to the β26/β4 β-strands and V1V2 and V3 
loop positioning. c, V1V2 and V3 loop positions. d, 3-stranded β-sheet (β20, β21, β3 β-strands) 
versus 4-stranded bridging sheet (β20, β21, β2, β3 β-strands). e, Fusion peptide conformation. f, 
gp41 HR1C helix conformation (gp120 N-terminal portion of gp41 removed for clarity). g, α0 
loop versus α0 helix conformation. 
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Supplementary Figure 1. Binding of HIV-1 antibodies to sCD4-Env or CD4m-Env 
complexes.  
ELISAs evaluating binding of IgG versions of anti-Env antibodies 17b, 21c, BG1, PG16, and 10-
1074 or control (no antibody added) to a, BMS-626529-BG505, b, sCD4-BG505 Env, c, BNM-
III-170-BG505 Env, and d, M48U1-BG505 Env. Values are shown as mean ± the standard 
deviation of duplicates for all measurements (some standard deviations are too small to be 
visible on the graphs). 
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Supplementary Figure 2. Data Processing for BNM-III-170-BG505-17b complex.  
a, Representative EM micrograph of data set showing sample particles (circled). b, Gold 
Standard 3D FSC chart for final reconstruction map using combined data sets. c, Particle 
orientation distribution and sphericity for final reconstruction of combined data sets. d, 
Schematic of processing pipeline. 
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Supplementary Figure 3. Data Processing for the M48U1-BG505-17b complex.  
a, Representative EM micrograph of data set showing sample particles (circled). b, Schematic 
of Processing pipeline. c, Gold Standard 3D FSC chart for final reconstruction map using 
combined data sets. d, Particle orientation distribution and sphericity for final reconstruction of 
combined data sets. e, Local resolution maps for density maps and overlay of 3D classes 
showing displacement of third protomer. 
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Supplementary Figure 4: 3D classification of BNM-III-170-BG505-17b shows differences 
in positioning of gp120 and 17b.  
a, Local resolution map of BNM-III-170-BG505-17b reconstruction. b, 3D classification scheme 
for BNM-III-170-BG505-17b after 2D class averages for Data Set 1 (particles binned x4) and 
after polishing particles and merging data.  c, Overlay 3D classes of BNM-III-170-BG505-17b 
produced after merging and polishing particles. Double-headed arrow on Protomer 3 shows 
direction of displacement of 17b and gp120 between 3D classes. d, Cartoon model overlay of 
Protomer 3 gp120 Phe43 pocket for all 3D classes. 
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Supplementary Figure 5: 3D classification of M48U1-BG505-17b shows differences in 
positioning of gp120 and 17b.  
a, Local resolution map of M48U1-17b reconstruction. b, 3D classification scheme for M48U1-
BG505-17b of un-binned particles after 2D classification. c, Overlay of 3D classes of M48U1-
BG505-17b. Double-headed arrow on Protomer 3 shows direction of displacement of 17b and 
gp120 between 3D classes. d, Cartoon model overlay of Protomer 3 gp120 Phe43 pocket for all 
3D classes. M48U1 helix removed for clarity. 
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Supplementary Figure 6. CD4m density is present within gp120 Phe43 cavity.  
a, Top-down view of BNM-III-170-BG505-17b density (top left) with regions containing BNM-III-
170 circled. Surrounding panels show zoomed-in views of densities (blue) for the BNM-III-170 
molecule and a cartoon/stick representation of the coordinates (BNM-III-170 = magenta, gp120 
= gray) in each protomer. Densities for protomers 1 and 2 are shown at 7σ and for protomer 3 at 
5σ. b, Top-down view of M48U1-BG505-17b density (top left) with regions containing M48U1 
circled. Surrounding panels show zoomed-in views of densities (blue) for the M48U1 molecule 
and a cartoon/stick representation of the coordinates (M48U1 = red, gp120 = gray) in each 
protomer. Density for protomer 1 is shown at 7σ and for protomers 2 and 3 at 5σ. 
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Supplementary Figure 7. Overlays of CD4m-gp120 core crystal structures with gp120 
core portions of structures of CD4m-BG505 Env trimer complexes.  
a, Alignment of BNM-III-170-gp120 core crystal structure (PDB 5F4P) and gp120 core regions 
from protomers 1, 2, and 3 of the BNM-III-170-BG505-17b complex. b, Alignment of M48U1-
gp120 core crystal structure (PDB 4JZZ) and gp120 core regions from protomers 1, 2, and 3 of 
M48U1-BG505-17b complex. 
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Table 1: Cryo-EM data collection, refinement and validation statistics 
 
 
 BNM-III-170- 
BG505 SOSIP.664-17b 
(Data Set 1) 
BNM-III-170- 
BG505 SOSIP.664-17b 
(Data Set 2) 
BNM-III-170- 
BG505 SOSIP.664-17b 
Combined Data 
(EMDB-AAAA;  
(PDB XXXX) 
M48U1- 
BG505 SOSIP.664-17b 
 
(EMDB-BBBB) 
(PDB YYYY) 
Data collection and 
processing 
    
Magnification    81, 000x 81, 000x 81, 000x 81, 000x 
Voltage (kV) 300 300 300 300 
Electron exposure (e–/Å2) 40 40 40 60 
Defocus range (μm) -1.5 to -3.5 -1.5 to -3.5 -1.5 to -3.5 -1.5 to -3.5 
Pixel size (Å) 1.104 1.104 1.104 1.104 
Symmetry imposed C1 C1 C1 C1 
Initial particle images (no.) 1040973 457694 n/a 627245 
Final  particle images (no.) 505426 158691 664117 263981 
Map resolution (Å) 
    FSC threshold 
4.0 
0.143 
4.6 
0.143 
3.7 
0.143 
3.9 
0.143 
Map resolution range (Å) n/a n/a 3.7 – 4.1 3.9 – 4.4 
     
Refinement     
Initial model used (PDB 
code) 
n/a n/a 6U0L, 5F4P, 2NXY 6U0L, 4JZZ, 2NXY 
Model resolution (Å) 
    FSC threshold 
n/a 
 
n/a 3.7 
0.143 
3.9  
0.143 
Model resolution range (Å) n/a n/a 3.67 – 3.8 3.8 – 4.0 
Map sharpening B factor 
(Å2) 
n/a n/a -124 -150 
Model composition 
    Non-hydrogen atoms 
    Protein residues 
    Ligands 
 
 
 
 
n/a 
n/a 
n/a 
 
n/a 
n/a 
n/a 
 
18113 
2199 
M AN: 11 
BMA: 3 
NAG: 52 
5VG: 3 
 
14497 
1999 
MPT: 3 
BMA : 3 
NAG: 14 
NH2: 3 
MAN: 6 
DPR: 3 
B factors (Å2) 
    Protein 
    Ligand 
 
n/a 
n/a 
 
n/a 
n/a 
 
64.22 
108.34 
 
50.06 
43.39 
R.m.s. deviations 
    Bond lengths (Å) 
    Bond angles (°) 
 
n/a 
n/a 
 
n/a 
n/a 
 
0.014 
1.078 
 
0.006 
1.101 
 Validation 
    MolProbity score 
    Clashscore 
    Poor rotamers (%)    
 
n/a 
n/a 
n/a 
 
n/a 
n/a 
n/a 
 
2.53 
19.75 
1.06 
 
2.27 
14.60 
0.31 
 Ramachandran plot 
    Favored (%) 
    Allowed (%) 
    Disallowed (%) 
 
n/a 
n/a 
n/a 
 
n/a 
n/a 
n/a 
 
81.65 
18.30 
0.05 
 
88.08 
11.87 
0.05 
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